MICHELLE LEYLAND: Open Payments
NPI 1184179673 · GROVEPORT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 16 payments from 13 companies in 2025. Trend: 2023 $192 · 2024 $252 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Verity Pharmaceuticals Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Exact Sciences Corporation | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: JOURNAVX, Tlando, TRELEGY ELLIPTA, Cologuard Collection Kit, CREON, XIFAXAN, FARXIGA, Veozah.
Industry payments across OH — which companies pay providers there.
